DERMATITIS, ATOPIC
Clinical trials for DERMATITIS, ATOPIC explained in plain language.
Never miss a new study
Get alerted when new DERMATITIS, ATOPIC trials appear
Sign up with your email to follow new studies for DERMATITIS, ATOPIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Real-World eczema drug study shows promise, but no cure yet
Disease control TerminatedThis study looked at how well the medication abrocitinib works for adults with moderate to severe atopic dermatitis (eczema) in everyday medical practice. About 112 participants in Germany were followed for up to 12 months after starting the drug. The goal was to see how many ach…
Matched conditions: DERMATITIS, ATOPIC
Sponsor: Pfizer • Aim: Disease control
Last updated May 26, 2026 06:59 UTC
-
Eczema drug study halted early: what we learned about Long-Term safety
Disease control TerminatedThis study tested the long-term safety of an experimental drug called GSK1070806 in adults with moderate to severe atopic dermatitis (eczema). It was designed for people who had already completed an earlier study of the same drug. The study was terminated early, so only limited s…
Matched conditions: DERMATITIS, ATOPIC
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated May 11, 2026 20:51 UTC
-
Eczema drug trial halted midway – what happened?
Symptom relief TerminatedThis study tested an experimental injection called GSK1070806 in adults with moderate to severe eczema (atopic dermatitis) who had already tried other treatments. The goal was to see if it could reduce eczema severity and itching. The trial was terminated early, so results are li…
Matched conditions: DERMATITIS, ATOPIC
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: Symptom relief
Last updated May 26, 2026 07:10 UTC